Biotech Bear Market: But It Is Time to Start Trading…11/9 Updates on Rally
Update at Close 11/9/18 Remain Cautious as Rally Fails The NASDAQ down 1.6% and Russell 2000 down 1.8%, sold off killing hopes of a continued Post-Election rally. The biotech sector is for experienced traders only. The healthcare still looks good overall with the XLV down only 0.29% at $92.95....
Biotech Bull Market Under Pressure: Now Flat to Down in 2018…Rally 10/16!…Updates 10/29 Bear Market
Update 10/29 It's a bear market in biotech so wait for the bottom. Have plenty of cash on hand. IBB at $102.77 down over 5% YTD. Clues: IJR and XBI need to bottom. ======= Update 10/27 Still on vacation, nothing to do . Impossible to trade or invest right now. Sentiment is crushed and numbers...
Biotech Momentum Lost Mired in Macro-Economic News Cycle: China, FED,Trade etc.
Biotech Momentum Lost Technical Breakdown: XBI Near April Bottom but XLV Looks Good Market Looking for Growth from Large Cap Earnings 10 year auction has tepid demand at Yield of 3.225%, NASDAQ at 7602 own 1.75% (Prices as of mid-day 1:30 p EDT) Biotech momentum losses were triggered by a...
Rayno BioBeat #6: Biotech Sell-Off with Broad Market Concerns…Updates
Update 10/5/18 Very Weak Technicals after Biotech Sell-Off NASDAQ market closed off the lows down 1.16% at 7788. Biotech ETF IBB down 1.15% just above 3 month support of 116. Biotech ETF XBI down 1.51% at 90.45 broke downtrend line and May support at 92. More losers again but a several winners:...
Mid-Cap Biopharma 2018 Stock Performance as of 9/30…Updates
Update-10/1 Rally Fades Early Today...NASDAQ Moves to Red An early rally faded quickly today after an initial spike from new "NAFTA" deal. Biotech ETFs were red IBB down 0.63% and XBI down 1.34%. Mid-Cap biopharmas were mainly red with CAR-T and gene editing stocks hit hard: BLUE CRSP EDIT...